| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.097 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.078 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.085 | 0.6 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |